TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 19 filers reported holding TRANSCODE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $357,000 | -20.1% | 324,157 | 0.0% | 0.22% | -16.7% |
| Q2 2022 | $447,000 | -52.1% | 324,157 | 0.0% | 0.26% | -39.0% |
| Q1 2022 | $934,000 | +24.4% | 324,157 | +9.7% | 0.43% | +15.9% |
| Q4 2021 | $751,000 | -15.0% | 295,540 | +0.0% | 0.37% | -6.5% |
| Q3 2021 | $884,000 | – | 295,518 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|